BLAC insider filings

Bellevue Life Sciences Acquisition Corp. — 12 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2023-03-27. Screen BLAC transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for BLAC between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.

Recent insider filings — Bellevue Life Sciences Acquisition Corp.

FiledFormInsiderReported transactionsSource
2023-03-274Hwang Kuk Hyoun — Chief Executive Officer, Director, 10% ownerOther (J): 20,000 @ $0 · Other (J): 20,000 (derivative) @ $0EDGAR
2023-03-274Bellevue Global Life Science Investors LLC — 10% ownerOther (J): 20,000 @ $0 · Other (J): 20,000 (derivative) @ $0EDGAR
2023-03-274Yoo David Jin — Chief Financial OfficerGrant/award (A): 20,000 @ $0 · Grant/award (A): 20,000 (derivative) @ $0EDGAR
2023-02-234Hwang Kuk Hyoun — Chief Executive Officer, Director, 10% ownerOther (J): 225,000 @ $0 · Other (J): 4,500 @ $0EDGAR
2023-02-234Bellevue Global Life Science Investors LLC — 10% ownerOther (J): 225,000 @ $0 · Other (J): 4,500 @ $0EDGAR
2023-02-164Chung In Chul — DirectorGrant/award (A): 20,000 @ $0 · Grant/award (A): 20,000 (derivative) @ $0EDGAR
2023-02-164Roberts Rad — DirectorGrant/award (A): 20,000 @ $0EDGAR
2023-02-164Park Jin Whan — DirectorGrant/award (A): 20,000 @ $0EDGAR
2023-02-164Euh Hosun — DirectorGrant/award (A): 20,000 @ $0EDGAR
2023-02-164Bellevue Global Life Science Investors LLC — 10% ownerOther (J): 20,000 @ $0 · Other (J): 20,000 @ $0 · Other (J): 20,000 @ $0 · Other (J): 20,000 @ $0 · Other (J): 20,000 @ $0 · Other (J): 225,000 @ $0 · +5 moreEDGAR
2023-02-164Hwang Kuk Hyoun — Chief Executive Officer, Director, 10% ownerOther (J): 20,000 @ $0 · Other (J): 20,000 @ $0 · Other (J): 20,000 @ $0 · Other (J): 20,000 @ $0 · Other (J): 20,000 @ $0 · Other (J): 225,000 @ $0 · +5 moreEDGAR
2023-02-164REED STEVEN — DirectorGrant/award (A): 20,000 @ $0 · Grant/award (A): 20,000 (derivative) @ $0EDGAR

Recent 8-K events — Bellevue Life Sciences Acquisition Corp.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2026-11-138-K4.01 — Changes in Registrant's Certifying Accountant
9.01 — Financial Statements and Exhibits
EDGAR
2026-10-288-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-10-168-K1.01 — Entry into a Material Definitive Agreement
9.01 — Financial Statements and Exhibits
EDGAR
2026-10-028-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2026-08-288-K8.01 — Other EventsEDGAR
2026-08-258-K8.01 — Other EventsEDGAR
2026-08-198-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-08-108-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
2026-08-078-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-07-318-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=BLAC returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs